Please click on the following link to place orders for OSUCCC Shared Resources:


The Pharmacoanalytic Shared Resource (PhASR) supports pre-clinical and clinical drug development at OSUCCC–James by providing high quality, cost-effective and reliable bioanalytical method development, quantitative sample analysis, and pharmacokinetic/pharmacodynamic/pharmacogenetic experimental design and data analysis.

PhASR’s goals are to provide the OSUCCC–James research and drug development community with:

  • High quality, state-of-the-art, cost-competitive analytical expertise and instrumentation for quantitation of drugs and metabolites in biological specimens
  • Pharmacokinetic data (real-time when possible) to enable pharmacologic data to be incorporated into clinical decision-making during dose escalation and interpretation of patient response and toxicity or in pre-clinical drug development efforts
  • Expertise in pharmacokinetic/pharmacodynamic/pharmacogenetic study design and data interpretation during submission of clinical protocols, grant proposals, study reports and publications

Director: Mitch Phelps, PhD 

Please contact us by completing the Customer Feedback Form.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: